---
title: "Charles River Labs director Nancy C. Andrews disposes of 573 common shares worth $163,442.52"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296533503.md"
description: "Charles River Laboratories director Nancy C. Andrews disposed of 573 common shares worth $163,442.52 on August 18, 2026. She exercised stock options at $164.3 per share and sold the shares at $285.24. Following the transaction, she retains 1,438 directly owned shares and holds 3,964 indirectly through a trust."
datetime: "2026-08-20T20:31:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296533503.md)
  - [en](https://longbridge.com/en/news/296533503.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296533503.md)
generator: "portal-rs"
---

# Charles River Labs director Nancy C. Andrews disposes of 573 common shares worth $163,442.52

-   Charles River Laboratories director Nancy C. Andrews exercised stock options on Aug. 18, 2026 for 573 shares at $164.3. \* She sold 573 shares the same day at $285.24, leaving 1,438 shares owned directly. \* She also reported 3,964 shares held indirectly through a trust. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001100682-26-000134), on August 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)

## Related News & Research

- [Insider Move at Charles River Labs: Director Cashes In on Company Stock](https://longbridge.com/en/news/296571643.md)
- [Charles River and MVC to develop enterovirus vaccine](https://longbridge.com/en/news/296594849.md)
- [Charles River Labs CEVP Shannon Parisotto disposes of shares worth $1,038,051.24](https://longbridge.com/en/news/295844385.md)
- [Charles River partners with Medigen Vaccine Biologics on NGS-backed multivalent enterovirus vaccine development](https://longbridge.com/en/news/296486690.md)
- [Charles River EVP, Chief People Officer Victoria Creamer sells 4,179 shares for $1.08 million](https://longbridge.com/en/news/295447796.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**